• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Anti-Aging
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management

Griseofulvin should remain standard in tinea capitis

Article

Munich - Newer oral antifungals have efficacy similar to griseofulvin in tinea capitis, possibly with a shorter duration of therapy. But for now, the old and familiar standby should remain the treatment of choice, according to Peter Mayser, M.D., senior physician, Justus Liebig University, Giessen, Germany.

Related Videos
Related Content
Experts Pen 12 Implementable Steps For Addressing Gender Inequity In Academic Dermatology

Experts Pen 12 Implementable Steps For Addressing Gender Inequity In Academic Dermatology

Article
The Cutaneous Connection: Make Data-Driven Decisions For Personalized AD Treatment

The Cutaneous Connection: Make Data-Driven Decisions For Personalized AD Treatment

Podcast
Secukinumab Demonstrates Promise for Patients With Severe Hidradenitis Suppurativa Who Found Adalimumab Intolerable

Secukinumab Demonstrates Promise for Patients With Severe Hidradenitis Suppurativa Who Found Adalimumab Intolerable

Article
ReV Up Your Vitiligo Treatment Strategies

ReV Up Your Vitiligo Treatment Strategies

Podcast
FDA Issues Alert on Counterfeit Botox: What Dermatology Clinicians Need to Know

FDA Issues Alert on Counterfeit Botox: What Dermatology Clinicians Need to Know

Article
New AAD Atopic Dermatitis Guidelines and Dupilumab Label Updates

New AAD Atopic Dermatitis Guidelines and Dupilumab Label Updates

Article
© 2024 MJH Life Sciences

All rights reserved.